Skip to main content

Table 1 Demographic and clinical characteristics of 32 patients infected with CRF65_cpx

From: Natural presence of the V179D and K103R/V179D mutations associated with resistance to nonnucleoside reverse transcriptase inhibitors in HIV-1 CRF65_cpx strains

Accession number

Subtype in the database

Sex

Risk factor

Sampling year

Geographic origin

ART

NNRTI resistance mutations

MG706585

CRF65_cpx

M

MSM

2014

Hebei

Treatment naive

V179D

KP698506

CRF65_cpx

M

NA

2011

NA

Treatment naive

V179D

KT379558

C

M

MSM

2012

Guangdong

Treatment naive

V179D

KR823099

C

M

MSM

2014

Beijing

Treatment naive

V179D

JQ898223

CRF65_cpx

M

IDU

2009

Yunnan

Treatment experienced

V179D, Y181C, H221Y

KR822879

C

M

MSM

2010

Beijing

Treatment naive

V179D

MG706490

CRF65_cpx

M

MSM

2014

Hebei

Treatment naive

V179D

KP250691

C

M

MSM

2009

Beijing

Treatment naive

V179D

MG706508

CRF65_cpx

M

MSM

2014

Hebei

Treatment naive

V179D

KP698505

CRF65_cpx

M

MSM

2010

Beijing

Treatment naive

V179D

KP698503

CRF65_cpx

M

MSM

2010

Beijing

Treatment naive

V179D

KX198586

CRF65_cpx

M

MSM

2013

Hebei

Treatment naive

K103R, V179D

KF714341

C

F

HET

2009

Yunnan

Treatment naive

V179D

KP698508

CRF65_cpx

M

MSM

2012

Beijing

Treatment naive

K103R, V179D

KP698504

CRF65_cpx

M

MSM

2010

Beijing

Treatment naive

K103R, V179D

KF714427

C

M

HET

2011

Yunnan

Treatment naive

V179D

KR822921

C

M

MSM

2011

Beijing

Treatment naive

K103R, V179D

KC183778

CRF65_cpx

M

MSM

2011

Anhui

Treatment naive

K103R, V179D

KF714326

C

M

HET

2009

Yunnan

Treatment naive

V179D

KP698507

CRF65_cpx

M

MSM

2012

Beijing

Treatment naive

V179D

KY713419

C

M

MSM

2016

Beijing

Treatment naive

K103R, V179D

KF714479

C

F

HET

2012

Yunnan

Treatment naive

V179D

MH051841

CRF65_cpx

M

MSM

2015

Jilin

Treatment naive

K103R, V179D

KF714310

C

F

HET

2009

Yunnan

Treatment naive

V179D

KF714461

C

F

HET

2012

Yunnan

Treatment naive

E138A, V179D

KC870030

CRF65_cpx

M

HET

2009

Yunnan

Treatment naive

V179D

KC870027

CRF65_cpx

F

HET

2010

Yunnan

Treatment naive

V179D

KF714363

C

F

HET

2010

Yunnan

Treatment naive

V179D

MF941253

C

NA

NA

2014

Heilongjiang

Treatment naive

K103R, V179E

KT625846

CRF65_cpx

NA

NA

2013

Yunnan

Treatment naive

V179D

KC870028

CRF65_cpx

F

HET

2010

Yunnan

Treatment naive

V179D

KF714374

BC

F

HET

2010

Yunnan

Treatment naive

V179D

  1. ART antiretroviral therapy, M male, F female, HET heterosexual, IDU intravenous drug user, MSM men who have sex with men, NA not available